Fortrea Holdings Inc. (FTRE)

Market Cap	1.73B
Revenue (ttm)	2.98B
Net Income (ttm)	-300.00M
Shares Out	89.70M
EPS (ttm)	-3.36
PE Ratio	n/a
Forward PE	15.81
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,266,058
Open	18.67
Previous Close	18.50
Day's Range	18.35 - 19.53
52-Week Range	16.53 - 41.02
Beta	n/a
Analysts	Hold
Price Target	23.30 (+20.98%)
Earnings Date	Nov 8, 2024

About FTRE

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 18,000
• Stock Exchange: NASDAQ
• Ticker Symbol: FTRE
• Website: https://www.fortrea.com

Analyst Forecast

According to 11 analysts, the average rating for FTRE stock is "Hold." The 12-month stock price forecast is $23.3, which is an increase of 20.98% from the latest price.

Price Target

$23.3

(20.98% upside)

Analyst Consensus: Hold